NCT05675384 is a NA clinical trial of TENS Active Treatment in Obesity, Mild, sponsored by Elira, Inc..

Who is sponsoring NCT05675384?

NCT05675384 is sponsored by Elira, Inc..

What drugs are being tested in NCT05675384?

Interventions in NCT05675384: TENS Active Treatment, Sham Device.

What condition does NCT05675384 study?

NCT05675384 studies Obesity, Mild.

Is NCT05675384 still recruiting?

NCT05675384 is currently completed. Last updated 31 July 2024.

Last reviewed 2024-07-31 · How we verify

NCT05675384

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Safety & Effectiveness of TENS Weight Management Compared to a Sham

Completed NA Last updated 31 July 2024

What this trial tests

NA trial testing TENS Active Treatment in Obesity, Mild in 395 participants. Completed in 23 July 2024.

Timeline

29 July 2022

Primary endpoint
23 July 2024

23 July 2024

Quick facts

Lead sponsor	Elira, Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	395
Start date	29 July 2022
Primary completion	23 July 2024
Estimated completion	23 July 2024
Sites	6 locations across United States

Drugs / interventions tested

TENS Active Treatment
Sham Device — full drug profile →

Conditions studied

Obesity, Mild — all drugs for Obesity, Mild →

Sponsor

Elira, Inc.

Who can join

Adults 18 to 65, any sex, with Obesity, Mild. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a multicenter, randomized, blinded, parallel group, controlled study intended to evaluate the safety and effectiveness of treating overweight and Class 1 obese patients with the Elira System (TENS active treatment) combined with a moderate intensity lifestyle follow-up compared to participants using the sham (control) device combined with a moderate intensity lifestyle follow-up

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Obesity, Mild

Currently open trials in the same condition.

NCT06114498 — Hospital Register of Decompensated Heart Failure With Preserved Ejection Fraction · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05675384 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Elira, Inc.
Last refreshed: 31 July 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05675384.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing